View More

The U.S. Food and Drug Administration authorized Covid-19 booster shots from Pfizer and Moderna on Wednesday that are targeted to the newest variants of the virus.

Arrow

View More

The Department of Health plans to start distributing an initial shipment of 17,000 doses on Sept. 6 or 7, assuming that the U.S. 

Arrow

View More

Centers for Disease Control and Prevention approves it later this week, said department spokesperson Ben Truman.

Arrow

View More

Vermont state epidemiologist Patsy Kelso told Vermont Public on Tuesday that boosters will be available at pharmacies and doctor’s offices.

Arrow

View More

The new shots contain viral material from SARS-CoV-2’s original strain as well as the BA.4 and BA.5 Omicron subvariants, 

Arrow

View More

the FDA reported, giving people who get it “increased protection against the currently circulating omicron variant.”

Arrow

View More

Anyone 12 years and older is eligible for the Pfizer vaccine, while the Moderna vaccine is only available to those 18 years and older, the agency reported.

Arrow

View More

This is the second booster dose the FDA has made eligible to the general public, after authorizing the first booster dose in 2021. 

Arrow

View More

It recommended another booster dose in March for high-risk people and people 50 years and older.

Arrow

When asked if the new boosters would also be available at the state’s remaining walk-in clinics, Truman said information specific to that would be posted soon on the department’s website.